Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.08.02.742322

An in vivo examination of Dynein-Cargo complex formation.

Abstract

Long-range intracellular transport relies on microtubule motors. This process is particularly important in large cells such as neurons and oocytes. While transport towards the plus-end of microtubules utilizes many kinesins, minus-end transport is largely mediated by a single motor, cytoplasmic dynein. Activation of dynein requires the large dynactin complex as well as a cargo adaptor. How dynein, dynactin, and adaptors assemble in vivo, particularly within specialized tissues such as the Drosophila egg chamber remains unclear. In the current study, we defined the dynein interactome in Drosophila egg chambers using in vivo proximity biotin ligation. Our findings suggest that Bicaudal-D (BicD) is the principal adaptor responsible for activating dynein and linking it with cargo in this tissue. We also identified Centrocortin (Cen) as a dynein adaptor in egg chambers. However, unlike BicD, loss of Cen did not affect dynein localization or apparent activation. To more specifically analyze adaptor-dependent assembly and cargo transport, we examined dynein light intermediate chain (Dlic) mutants known to impair adaptor binding. As expected, these mutants disrupted the BicD-dynein interaction. However, Cen remained associated with the dynein/dynactin complex in the mutant background, suggesting that Cen engages the motor by a different mechanism. Finally, live imaging of microtubules revealed that even when adaptor binding is compromised, dynein-driven microtubule gliding can still deliver nurse cell-derived cargo into the oocyte, albeit with reduced efficiency. Collectively, our results reveal multiple, mechanistically distinct routes for adaptor association with dynein in vivo and indicate that redundant processes can sustain cargo transport during oogenesis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Allen, P., Neiswender, H., Lu, W., Lakonishok, M., Veeranan-Karmegam, R., Pride, J., Gelfand, V. I., Gonsalvez, G. B.. 2026-08-04. An in vivo examination of Dynein-Cargo complex formation.. https://doi.org/10.64898/2026.08.02.742322

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Nucleosome Core Allostery Governs Chromatin Recognition and Cell Fate

Nucleosomes regulate chromatin folding, accessibility, and factor recruitment. Current models primarily attribute these functions to histone tail modifications, while the core is largely viewed as a structural scaffold. Yet subtle changes within the nucleosome core can produce profound functional consequences, and the mechanisms underlying these effects remain unclear. Here, we describe nucleosome core allostery as a fundamental principle of chromatin regulation that amplifies the impact of minimal nucleosome variations. Leveraging natural differences between H2A.Z variants, we show that the nucleosome core encodes distinct conformational dynamics that propagate allosterically, thereby controlling nucleosome accessibility and recognition by chromatin factors. As a result, a single buried amino acid substitution alone is sufficient to reprogram nucleosome dynamics and bias cell identity. Our findings establish the nucleosome core as an allosteric regulatory module and provide a generalizable framework for how subtle variation within nucleosomes is amplified into diverse biological outcomes in development and disease.

cell biology↗

SOX4 Reprograms Adipose Stromal Cells into a Cancer-Associated Fibroblast-like State to Drive Metabolic Disease

Pathogenic adipose tissue remodeling promotes metabolic disease in obesity, but the mechanisms that establish this unhealthy tissue state remain poorly understood. Here, we show that obesity drives SOX4-dependent reprogramming of mesenchymal stromal cells (MSCs) into cancer-associated fibroblast-like (CAF-like) cells that promote adipose tissue dysfunction. TGF{beta} signaling is elevated in obesity and activates SOX4 in mouse and human MSCs, inducing their conversion to a CAF-like state. In mice, MSC-specific SOX4 activation induces the CAF-like program and exacerbates adipose tissue inflammation and glucose intolerance, whereas Sox4 deletion attenuates inflammation and improves glucose homeostasis during obesity. We further identify the growth factor Midkine (MDK) as a SOX4-regulated paracrine effector produced by CAF-like cells. MDK inhibition in obese mice reduces adipose tissue inflammation and improves metabolic function. Together, these findings define a TGF{beta}-SOX4-MDK stromal signaling axis that drives pathological adipose tissue remodeling in obesity and highlight this pathway as a potential therapeutic target for improving metabolic health.

cell biology↗

PDLIM5 Modulates YAP1 Localisation and Fibrogenic Gene Expression in Hepatic Stellate Cells

Hepatic stellate cells (HSCs) are the key cellular drivers of liver fibrosis. During liver injury and chronic inflammation HSCs adopt an activated phenotype and secrete fibrotic extracellular matrix (ECM) components such as collagen 1. Mechanical cues derived from the fibrotic ECM drive and support the activation of HSCs, via mechanisms that involve integrins and the mechano-sensitive transcriptional regulator YAP1. It is not yet well understood how external mechanical cues are translated into a molecular response that alters YAP1 nuclear shuttling. There is evidence that suggests the PDZ and LIM domain protein (PDLIM) 5 can regulate YAP1 shuttling in human epithelial cells. We therefore investigated whether PDLIM5 is expressed in HSCs and contributes to YAP1 associated HSC mechano-activation. PDLIM5 protein was detected in HSCs in fibrotic human and mouse liver. PDLIM5 transcript and protein were expressed by primary human and mouse HSCs and by the immortalised HSC LX-2 cell line. PDLIM5 localised with actin stress fibres suggesting a role in HSC adhesion. Co-immunoprecipitation and proximity ligation in LX-2 cells support an association between PDLIM5 and YAP1. We used pharmacological (paclitaxel) and genetic (siRNA and CRISPRi) approaches to inhibit PDLIM5 in HSCs. Inhibiting PDLIM5 reduced YAP1 nuclear localisation and fibrotic gene (COL1A1, ACTA2) expression in LX-2 cells. Overall, these data support a role for PDLIM5 in regulating YAP1 localisation and fibrogenic gene expression in HSCs.

cell biology↗